Word: gehrigã
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...therapy. “Modulating the activity of astrocytes might be an interesting therapeutic target slightly different than the neurocentric view,” said Kuchibhotla. Since this research can be applicable to other diseases—including Parkinson’s, Huntington’s, and Lou Gehrig??��s disease—Bacskai and researchers at MIND are in the process of using these imaging techniques to study other neurodegenerative diseases. “The point of MIND is to have all the researchers in an open lab environment,” said Anne B. Young...
...technique could also be applicable, for example, to other disorders that affect the cardiovascular or nervous system such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig??��s disease), as scientists could potentially grow heart or nerve cells...
Researchers at the Harvard Medical School (HMS) and Quebec’s Laval University said they are on the verge of finding a vaccine for the inherited form of Lou Gehrig??��s disease, a condition in which a mutated protein destroys a person’s capacity for muscle control. The work conducted by Robert H. Brown Jr., associate professor at HMS, and Jean-Pierre Julien, a research chair at Laval University, is part of a growing trend in the search for vaccines against genetic diseases, including Alzheimer’s and Parkinson’s Diseases. Instead...
Researchers from Harvard and Columbia have moved one step closer to discovering the cause of the fatal neurodegenerative Lou Gehrig??��s disease through a novel use of embryonic stem cells from mice. Supporters of embryonic stem cell research have long pointed to the potential to use these cells to directly treat diseases of the nervous system. But the Harvard and Columbia teams assert that stem cells have a broader application in providing critical information for understanding many other human diseases. The researchers have harnessed stem cells from mice embryos, which can develop into any kind of tissue...
...diagnosed last fall with amyotrophic lateral sclerosis (ALS).Since Kremer was first diagnosed, this second-year Business School student has raised over two million dollars, facilitated discussions between competing pharmaceutical companies, and founded two companies dedicated to discovering a treatment for ALS—commonly known as Lou Gehrig??��s disease. Kremer will graduate this week from the Business School and receive the prestigious Dean’s Award for his devotion to increasing ALS research and awareness.“I always said I will walk and shake the hand of the dean...